Researchers report that patients with knee osteoarthritis have achieved significant short-term pain relief with ultrasound-guided genicular nerve blocks (GNB), locally injected anesthetics that block nerves around the knee… read more.
Among patients diagnosed with atrial fibrillation (AF) and valvular heart disease (VHD), those treated with apixaban have achieved a lower rate of ischemic stroke or systemic embolism and… read more.
Pregnant women with severe preeclampsia taking a daily dose of blood pressure lowering nifedipine as labor is induced have achieved better blood pressure control during labor and were… read more.
A low-carb diet enables persons at risk of Type 2 diabetes to lower their blood sugar before the onset of that disease, researchers reported on Oct.26, 2022 in… read more.
Findings from a global study suggest that risk factors for cardiovascular disease are similar for men and women, with some notable differences. The outcomes were reported on Oct…. read more.
Researchers report that patients with advanced cutaneous squamous cell carcinoma, a skin cancer and one of the most frequent malignancies worldwide, benefit from treatment with the immune checkpoint… read more.
Researchers report a link between use of glitazones to treat type 2 diabetes and a 22% reduced risk of dementia. The findings appeared on Oct 11, 2022 in… read more.
A large retrospective study of patients diagnosed with atrial fibrillation (AF) and valvular heart disease (VHD) showed that apixaban treatment was associated with a lower rate of ischemic… read more.
Researchers reported a 20 percent advantage in the two-year overall survival rate for subjects with advanced melanoma and a mutation in the BRAF gene, specifically a BRAF V600 mutation, who were initially… read more.
Persons infected with the COVID-19 virus are at an increased risk of developing neurological conditions in the first year after infection, researchers reported on Sept. 22 in Nature… read more.
Tenecteplase, a clot buster used off-label for treating ischemic stroke, outperforms alteplase, the standard treatment, in health outcomes and cost, researchers reported on September 23, 2022 in Stroke…. read more.
Treatment with the biologic drug dupilumab brings relief to children younger than 6 years-old who are suffering with moderate-to-severe atopic dermatitis (eczema) The findings were published on Sept…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
